Alianzas de compañías biofarmacéuticas líderes como eje estratégico para el desarrollo de vacunas anti- COVID-19 / Alliances of leading biopharmaceutical companies as a strategic axis for the development of anti-COVID-19 vaccines
Rev. cuba. med. mil
;
50(2): e1193, 2021.
Article
in Spanish
| LILACS, CUMED
| ID: biblio-1341406
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Biopharmaceutics
/
COVID-19
/
Vaccine Development
Limits:
Humans
Language:
Spanish
Journal:
Rev. cuba. med. mil
Journal subject:
History of Medicine
/
Military Medicine
Year:
2021
Type:
Article
Affiliation country:
Cuba
Institution/Affiliation country:
Universidad de Ciencias Médicas de la Habana/CU
/
Universidad de Ciencias Médicas de las Fuerzas Armadas Revolucionarias/CU
Similar
MEDLINE
...
LILACS
LIS